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Background: Rhabdomyolysis presenting with severe hypokalemia as the first manifestation of primary
hyperaldosteronism is extremely rare.
Case presentation: Two middle-aged Chinese females were admitted to our emergency department for muscular
weakness and limb pain, and both have the history of early onset hypertension. Laboratory test showed elevated
creatinine phosphokinase (4, 907 and 8, 531 IU/L) and extremely low serum potassium (1.38 mmol/L and 1.98
mmol/L). Rhabdomyolysis and severe hypokalemia were established as first diagnosis. Hypokalemic rhabdomyolysis
was confirmed after nervous system disorders, autoimmune diseases and trauma were excluded. Adrenal
computerized tomography scan and postural stimulation test revealed aldosterone-producing adenomas. They
both received laparoscopic adrenalectomy and were stable at the 2-year follow-up visit.
Conclusion: The two cases remind physicians to bear in mind the risk of hypokalemia-induced rhabdomyolysis
among patients with primary hyperaldosteronism.Background
Primary hyperaldosteronism (PHA) is a common cause of
secondary hypertension. The main clinical manifestations
are resistant hypertension and hypokalemia. Hypokalemia
induced by PHA is a chronic process and most patients
can tolerant the symptoms of malaise, muscular weakness
and fatigability. But in some extreme conditions, PHA can
induce excessive potassium excretion followed by rhabdo-
myolysis. Rhabdomyolysis presenting with severe hypo-
kalemia as the first manifestation is rare in primary




A 45-year-old Chinese female presented herself with fatigue
and limb pain since 10 days in the emergency department.
A slight pain in the right femoribus internus gradually ag-
gravated in severity and extent during the following 10
days, and progressively got the upper limbs, back and neck
involved in. She reported about a four-year history of* Correspondence: weimi003@yahoo.com.cn
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reproduction in any medium, provided the orarterial hypertension treated with nitrendipine and capto-
pril. She denied any acute infections, trauma or intoxica-
tion. Physical examination revealed slightly elevated blood
pressure (143/80 mmHg) and tenderness in the limb
muscles. The laboratory examinations (Table 1) showed
extremely low serum potassium (1.38 mmol/L) and ele-
vated CPK (4, 907 IU/L). Electrocardiogram (ECG) showed
Q-T interval elongation and abnormal U wave.
Based upon these clinical features, we established hypo-
kalemia and rhabdomyolysis as first diagnosis. A series of
laboratory examinations were performed for differential
diagnosis of rhabdomyolysis. Biopsy results of right biceps
brachii muscle revealed degenerated and necrotic muscle
fibers with some inflammatory cells infiltrating the peri-
mysium. The electromyogram was normal, which excluded
nervous system disorders. Rhabdomyolysis induced by
autoimmune diseases were excluded for negative results of
autoimmune antibodies.
Hence, we supposed hypokalemia induces rhabdomyoly-
sis. Tests for synchronous serum and urine potassium
(First time: serum potassium 3.10 mmol/L, urine potas-
sium 57.98 mmol/24 h; Second time: serum potassium
2.87 mmol/L, urine potassium 48.63 mmol/24 h) illus-
trated excessive potassium loss. Normal pH in arterial
blood eliminated the suspect of renal tubule diseases.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Laboratory data on admission







WBC 11.40 × 109/L 8.38 × 109/L
RBC 4.71 × 1012/L 4.68 × 1012/L
Hb 129 g/L 139 g/L
Hct 0.39 L/L 0.39 L/L
Plt 158 × 109/L 255 × 109/L
Blood Chemistry
Alb 47.1 g/L 37.4 g/L
TBIL 17.0 umol/L 13.8 umol/L
ALT 61 IU/L 46 IU/L
AST 123 IU/L 115 IU/L
GLU 6.56 mmol/L 5.33 mmol/L
BUN 7.15 mmol/L 2.69 mmol/L
Cre 92.7 umol/L 58.8 umol/L
UA 297.5 umol/L 176.0 umol/L
Myo 28.28 ng/ml
CHOL 4.56 mmol/L 4.00 mmol/L
TG 1.63 mmol/L 2.94 mmol/L
HDL-C 1.56 mmol/L 0.83 mmol/L
CK 4907 IU/L 8531 IU/L
LDH 477 IU/L 335 IU/L
Na 142.1 mmol/L 146.0 mmol/L
K 1.38 mmol/L 1.98 mmol/L
Cl 98.7 mmol/L 97.8 mmol/L
Arterial Blood Gas Analysis on Room Air
pH 7.432 7.487
pO2 72.0 mmHg 75.2 mmHg
pCO2 37.4 mmHg 43.1 mmHg
HCO3- 24.4 mmol/L 31.9 mmol/L
BE 0.4 mmol/L mmol/L
Table 2 Endocrine test results
Case 1 Case 2 Reference range
Basal endocrine data: before postural stimulation test
PRA 0.84 0.07 0.05-0.84 ng/ml.h
AT-II 28.61 43.63 28.2-52.2 ng/L
PAC 639.38 449.70 45-175 ng/L
ARR 76.12 642.43 ng/dl:ng
NE <50 59 174-357 ng/L
E <50 <25 60-104 ng/L
TSH 4.180 6.360 0.27-4.2 mU/L
T3 2.21 1.3-3.1 nmol/L
T4 129.30 62-164 nmol/L
FT3 4.42 3.60-7.50 pmol/L
FT4 17.59 12.0-22.0 pmol/L
Endocrine data: 2 hours after postural stimulation test
PRA 0.17 0.56-2.79 ng/ml.h
AT-II 49.54 29.0-71.6 ng/L
PAC 265.80 98-275 ng/L
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ated. Pain and weakness were relieved and serum CPK
levels normalized within one week. However, the serum
potassium level remained low (3.00 mmol/L) despite po-
tassium supplementation.
Increased Aldosterone to Renin ration (ARR) indicated
PHA (See Table 2 and Figure 1). Adrenal imaging with
computerized tomography (CT) scan showed a low-density
mass measuring 2.1 cm in diameter in the left adrenal
(Figure 2). After initiation of spironolactone treatment,blood pressure and potassium levels in serum and urine
returned to normal within one week.
Case 2
Another Chinese female with 44 years old was admitted to
our hospital with similar symptoms and signs of fatigue
and limbs pain. Serum potassium was 1.98 mmol/L with
highly elevated serum CPK levels (8, 531 IU/L). ECG
showed highly elongated Q-T interval and abnormal ap-
parent U wave. Differential work-up for hypokalemia and
rhabdomyolysis showed PHA was the diagnosis (see Table 2
and Figure 1). CT scan revealed an adrenal gland mass with
1.6 cm in diameter (Figure 3). Symptoms were relieved
after treatment with potassium and spironolactone.
Both patients were treated with laparoscopic left adre-
nalectomy. Postural stimulation test and adrenal histology
showed aldosterone-producing adenomas (Table 2 and
Figure 4). Until the two year follow-up visit, the patients
did not complain about similar symptoms anymore, and
the blood pressures and potassium levels remained in a
normal range.
Discussion
Rhabdomyolysis is defined as a pathological condition of
skeletal muscle cell damage leading to the release of toxic
intracellular material into the blood circulation, such as
CPK, myoglobin, aspartate aminotransferase, alanine ami-
notransferase and potassium [1-3]. The syndrome gene-
rally presents with the triad muscular pain, weakness and
reddish brown urine [4].
Figure 1 Adrenal imaging of case 1. Nodular mass (diameter
approximately 21 mm) on the left adrenal gland, and the right
adrenal gland appears normal.
Figure 3 Adrenal imaging of case 2. Nodular mass (diameter
approximately 16 mm) on the left adrenal gland.
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ischemia, drugs, toxins, metabolic disorders, infections
and electrolyte disorders [5,6]. Especially, severe hypo-
kalemia might play an important role in muscle cell
damage [7,8]. Local potassium levels in capillaries are im-
portant regulators for vascular tension. Severe hypoka-
lemia contracted capillaries, reduced muscle blood supply
and finally resulting in lysing muscle cells and muscle cell
damage [9,10]. Frank rhabdomyolysis usually occurs only
when serum potassium values are below 2.0 mmol/L
[8,11], which possibly induces cardiac arrhythmia and
needs emergency treatment.
In PHA, aldosterone excess leads to water-sodium re-
tention and potassium excretion. Patients usually present
with hypertension and mild hypokalemia, while malaise
and muscular weakness is always tolerable for patients.Figure 2 Adrenal histology of case 1. Fine connective tissue septa
separate adrenal cortical clear cells nodules and the histopathology
of resected specimen shows adenoma (HE × 100 and HE × 400).When vomiting or diarrhea occur or diuretics are used,
serum potassium levels might drop to very low levels [12].
Although rhabdomyolysis usually results in hyper-
kalemia due to the direct release of intracellular potassium
into the extracellular fluid, over-excreted aldosterone in
PHA induces potassium excretion into urine. These
mechanisms might be the reason we find hypokalemia, in-
stead of hyperkalemia, resulting from rhabdomyolysis in
those two cases.
Conclusion
The diagnosis of PHA might be difficult when rhabdo-
myolysis and severe hypokalemia are the first manifest-
ation. However, when rhabdomyolysis and hypokalemia
occur in hypertensive patients, PHA should be consi-
dered. Further investigation for PHA should be initiated.Figure 4 Adrenal histology of case 2.Adrenal cortical clear cells
nodules is around by fine connective tissue septa and the histopathology
of resected specimen shows adenoma (HE × 100 and HE × 400).
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